Eruptive keratoacanthomas secondary to nivolumab immunotherapy

E-ISSN： 1365-4632|57|3|e28-e29

ISSN： 0011-9059

Source： INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol.57, Iss.3, 2018-03, pp. : e28-e29

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Eruptive keratoacanthomas arising in the setting of lichenoid toxicity after programmed cell death 1 inhibition with nivolumab

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 32, Iss. 2, 2018-02 ,pp. : e58-e59

John Wiley & Sons Inc

Access to resources Recommend Favorite

Response to ‘Eruptive keratoacanthomas arising in the setting of lichenoid toxicity after patients on antiprogrammed cell death‐1 inhibition with nivolumab’

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 32, Iss. 2, 2018-02 ,pp. : e61-e62

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dramatic Response of a Metastatic Primary Small-Cell Carcinoma of the Pancreas to a Trial of Immunotherapy with Nivolumab: A Case Report

Case Reports in Oncology, Vol. 10, Iss. 2, 2017-08 ,pp. : 720-725

Karger

Access to resources Recommend Favorite

Autoimmune Hemolytic Anemia as a Complication of Nivolumab Therapy

Case Reports in Oncology, Vol. 9, Iss. 3, 2016-11 ,pp. : 691-697

Karger

Access to resources Recommend Favorite

Nivolumab-Induced Pericardial Tamponade: A Case Report and Discussion

Cardiology, Vol. 136, Iss. 1, 2016-08 ,pp. : 49-51

Karger

Access to resources Recommend Favorite